At the core of CRC tumorigenesis lies the constitutive activation of the RAS/RAF/MEK/ERK pathway, modulated by gene mutations and regulatory actions of RAS and BRAF [2]. The gene discussed is MAP2K7; the disease is colorectal carcinoma.